recent post

WHO approves first mpox diagnostic test by Abbott Molecular

October 5, 2024
recent post

KIMS Hospitals signs MoU with Intuitive

October 4, 2024
recent post

Centre for Dental Education & Research organises conclave on oral health

recent post

Turbostart leads $­­1 M investment in Ai Health Highway

recent post

CCI approves acquisition of Bharat Serums and Vaccinesby Mankind Pharma

imt Logo cross btn

Lupin, Scope sign distribution agreement

Lupin, Scope sign distribution agreement

To commercialise Optase range of products in Mexico
                                                              
Lupin has signed a distribution agreement with Scope Ophthalmics Ireland (SCOPE) for the registration and marketing of a Moist Heat Mask, a Tea Tree Oil Eyelid Cleansing Gel and Tea Tree Oil Eyelid Wipes of the OPTASE range, in Mexico.
 
The OPTASE range is a safe, tested and expert-recommended 3-step regime to help tackle the cause and symptoms of eye conditions such as Dry Eyes, Blepharitis and Meibomian Gland Dysfunction (MGD). This eye care routine comprising Heat, Cleanse and Hydrate, follows the TFOS Dry Eye management strategy, as outlined in the DEWS II publication's staged plan.
 
“We are pleased to collaborate with SCOPE and integrate a part of their OPTASE range of products into our Ophthalmology offerings. This expansion of our Ophthalmology range reinforces our commitment to enhancing vision care for our patients, improving their quality of life,” said Dr Fabrice Egros, President – Corporate Development and Growth Markets, Lupin.
 
“Through the signature of this collaboration with Lupin, SCOPE is expanding its footprint in Latin America for its OPTASE range. Mexico is a country of strategic importance for SCOPE where our innovative eyecare products, together with the strong relationships of Lupin amongst Eye Care Professionals as well as its overall credibility in the market, will certainly contribute to the success of both companies,” said Tom Freyne, CEO, SCOPE.